At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 124 enrolled
Drug / intervention
moxifloxacin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Single Blinded Clinical Trial Comparing Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution for Treatment of Conjunctivitis.
In Brief
A Phase 4 clinical trial evaluating moxifloxacin and polytrim for Conjunctivitis. Completed, enrolled 124 participants across 1 site.
Detailed Summary
The purpose of the study is to compare the effect of Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution in treating your child's pink eye. Both these medications are approved by the Food and Drug Administration, for treatment of conjunctivitis. This study will investigate if both of the medications are equally good.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsConjunctivitis
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2007
First PostedDec 2007
Primary CompletionMar 2009
Study CompletionMar 2012
TodayJul 2026
First PostedDec 27, 2007
Enrollment StartMar 1, 2007
Primary CompletionMar 1, 2009
Study CompletionMar 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 18.5 years ago
Interventions
moxifloxacindrug
1-2 drops three times a day for 8-10 days.
polytrimdrug
1-2 drops four times a day for 8-10 days.